Abstract
von Willebrand disease (vWD) is a bleeding disorder that is predominantly attributable to reduced levels of von Willebrand factor (vWF) activity. vWD prevalence is 1% in the population and vWD Type 3 is very rare. vWD Type 3 is inherited as autosomal recessive manner and accounts for less than 5% of all cases. Individuals with vWD type 3 can have a severe internal and joint bleeding. However, type 3 and type 2 variants are extremely difficult to manage and there is no guarantee that haemostasis will be achieved even when plasma concentrations have apparently been corrected into the normal range. We report a female child aged 10 years presented to us with heavy menstrual bleeding for three days which continued for another seven days. This episode was after recent onset of menarche and was diagnosed as having vWD Type 3. It was considered as a life threatening bleeding. Immediate and long term management of this patient with a major bleed was a daunting task. She was treated with Intermediate purity factor viii/ factor viii (cryoprecipitate), activated factor vii, Blood and antifibrinolytics. Long term endometrial suppression was the key to hinder excessive bleeding during menstruation (which could be life threatening) as she would need prophylaxis during each episode. Selecting the correct method which suits her best was not without difficulty. Intrauterine use of Mirena (levonogestrel-releasing intrauterine system-LNG-IUS) Was a better option and there are very few reports if at all of its use in a similar situation. We have used it as a novel method to suppress excessive menstrual bleeding (long term) in this patient with von Willebrand disease type 3.
Highlights
Introduction vonWillebrand disease is a bleeding disorder that is predominantly attributable to reduced levels of Von Willebrand factor activity
We report a female child aged 10 years presented to us with heavy menstrual bleeding for three days which continued for another seven days. This episode was after recent onset of menarche and was diagnosed as having von Willebrand disease (vWD) Type 3
We have used it as a novel method to suppress excessive menstrual bleeding in this patient with von Willebrand disease type 3
Summary
Use of Mirena (Levonorgestrel-releasing intrauterine system) in menorraghia in a young female with von Willebrand disease (vWD) Type 3 - A case report. Von Willebrand disease (vWD) is a bleeding disorder that is predominantly attributable to reduced levels of von Willebrand factor (vWF) activity. We report a female child aged 10 years presented to us with heavy menstrual bleeding for three days which continued for another seven days This episode was after recent onset of menarche and was diagnosed as having vWD Type 3. We have used it as a novel method to suppress excessive menstrual bleeding (long term) in this patient with von Willebrand disease type 3. Introduction von Willebrand disease (vWD) is a bleeding disorder that is predominantly attributable to reduced levels of Von Willebrand factor (vWF) activity. Type 3 and type 2 variants are extremely difficult to manage and there is no guarantee that haemostasis will be achieved even when plasma concentrations have apparently been corrected into the normal range[4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
